References
- 1. Agha-Mir-Salim P, Stange T, Knipping S, Jahnke V, Berghaus A. Electron microscopic studies of the rabbit nasal mucosa after short-term application of naphzoline nitrate. Laryngorhinootologie. 2001;80(7):389-93.10.1055/s-2001-15715
- 2. . Bucaretchi F, Dragosavac S, Vieira RJ. Acute exposure to imidazoline derivatives in children. J Pediatr (Rio J). 2003;79(6):519-24.10.2223/JPED.1112
- 3. Chapman RA, Leoty C. Which of caffeine’s chemical relatives are able to evoke contractures in mammalian heart? Recent Adv Stud Cardiac Struct Metab. 1975;7:425-30.
- 4. Coca-Prados M, Escribano J, Ortego J. Differential gene expression in the human ciliary epithelium. Prog Retin Eye Res. 1999;18(3):403-29.10.1016/S1350-9462(98)00026-3
- 5. Corey JP, Houser SM, Ng B A. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J. 2000;79(9):690-702.10.1177/014556130007900908
- 6. Costantino G, Ceriani E, Sandrone G, Montano N. Ischemic stroke in a man with naphazoline abuse story. Am J Emerg Med. 2007; 25(8):983.10.1016/j.ajem.2007.02.01817920988
- 7. Craver BN, Chase F, Yonkman FF. Pharmacologic studies of a new vasoconstrictor: 2-Naphthyl-1′-Methyl-imidazoline hydrochloride (Privine or Naphthazoline: J Pharmacol Exper Therap. 1944;82(3):275-87.
- 8. De Groot AC. Patch testing. 3rd edition: Update 2008 – 2015. Wapserveen, The Netherlands: acdegroot publishing; 2015:33.
- 9. Di Lorenzo C, Coppola G, La Salvia V, Pierelli F. Nasal decongestant and chronic headache: a case of naphazoline overuse headache? F1000Res. 2013;2:237.
- 10. Drugs in Japan. Ethical Drugs. 6th edition. Japan: Yakugyo Jiho Co., Tokyo; 1982:612.
- 11. Fukushima H et al.: Acute pulmonary edema associated with naphazoline ingestion. Clin Toxicol (Phila). 2008;46(3):254-6.10.1080/1556365070143844117852165
- 12. Hild AM. Privine Ciba, a new preparation for reducing congestion of the nasal mucosa. Schweiz med Wchnschr. 1941;71:557-61.
- 13. Johnson DA, Hricik JG. The pharmacology of alpha-adrenergic decongestants. Pharmacotherapy. 1993;13(6 Pt 2):110-115.10.1002/j.1875-9114.1993.tb02779.x
- 14. Kahn CM, The Merck Veterinary Manual. 9th edition. Whitehouse Station, NJ, [Great Britain]: Merck & Co.; 2005:2526.
- 15. Kampi Yu, Dyachuk V. Peculiarities of clinical features of poisoning by topical (nasal) decongestants of children. Scientific bulletin of Uzhhorod university, series Medicine. 2013;48:58-62.
- 16. Lee DH, Yun S Y, Cho KH, Lee HM, Choi YH. A case of naphazoline intoxication after the ingestion of a topical antiseptic solution. Hong Kong J Emerg Med. 2010;17:364.10.1177/102490791001700409
- 17. Lopatin A S. Nasal decongestants: old drugs and new formulations. Doktor.Ru. 2011;65(6):13-9.
- 18. Lopes LM, Carrilho MC, Francisco RP, Lopes MA, Krebs VL, Zugaib M. Fetal ductus arteriosus constriction and closure: analysis of the causes and perinatal outcome related to 45 consecutive cases. The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(4):638-45.10.3109/14767058.2015.101541325708490
- 19. Lowry JA, Brown JT. Significance of the imidazoline receptors in toxicology. Clinical Toxicology. 2014;52(5):454-69.10.3109/15563650.2014.89877024666288
- 20. Maling HM, Gho AK, Horakova Z, Williams M. A. The pharmacologic effects of ST-155 (Catapres) and related imidazolines in the rat. Pharmacology. 1969;2(6):337-51.10.1159/0001360385362409
- 21. Marushko Y. Experience of application of topical decongestants in children of early age. Lechaschiy Vrach. 2010;11:86.
- 22. Mashige KP. Ocular allergy. Health SA Gesondheid. 2017;22:112-22.10.1016/j.hsag.2016.07.001
- 23. McEvoy GK. AHFS Drug information 2006, Naphazoline hydrochloride, Bethesda: American Society of Health-System Pharmacists. 2006:2827-8.
- 24. McGrath JC. Localization of α-adrenoceptors: JR Vane Medal Lecture. British journal of pharmacology. 2015;172(5):1179-94.10.1111/bph.13008
- 25. Mortuaire G et al. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. European annals of otorhinolaryngology, head and neck diseases. 2013;130(3):137-44.10.1016/j.anorl.2012.09.005
- 26. Munaron L. Shuffling the cards in signal transduction: Calcium, arachidonic acid and mechanosensitivity. World J Biol Chem. 2011;2(4):59-66.10.4331/wjbc.v2.i4.59
- 27. Musshoff F, Gerschlauer A, Madea B. Naphazoline intoxication in a child - a clinical and forensic toxicological case. Forensic Science International. 2003;134(2):234-7.10.1016/S0379-0738(03)00158-0
- 28. Nurmukhametov R.: Vasoconstrictors (decongestants). Consilium provisorum. 2001;1(1): 21-3.
- 29. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced neuroendocrine changes: Increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002;65(3):155-61.10.1159/00005804212037379
- 30. Ogidigben MJ, Chu TC, Potter DE. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res. 2001;72(3):331-9.10.1006/exer.2000.096011180982
- 31. Ono Y, Ono N, Shinohara K. Tissue hypoperfusion, hypercoagulopathy, and kidney and liver dysfunction after ingestion of a naphazoline-containing antiseptic. Case reports in emergency medicine 2017. 2017.10.1155/2017/3968045543883828555165
- 32. Ortego J, Coca-Prados M. Functional expression of components of the natriuretic peptide system in human ocular nonpigmented ciliary epithelial cells. Biochem Biophys Res Commun. 1999;258(1):21-8.10.1006/bbrc.1999.057310222228
- 33. Pukhlik SM. Nasal Decongestants – Pros and Cons. Rhinology. 2004;4:36-51.
- 34. Putnam LE, Herwick RP. Privine dependence of two years’ duration. JAMA. 1946; 130(11):702-3.10.1001/jama.1946.0287011002600821016281
- 35. Radtsig EU, Ermilova NV, Sapaeva NV, Bogomil’sky MR. Alternative to topical decongestants for symptomatic treatment of children’s acute rhinitis. Current pediatrics. 2007;6(5):92-5.
- 36. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148-55.
- 37. Rosati GF, Poletto MG. Pharmacological characteristics of alphamethyl-beta-[2-methylene-4,5-dihydroimidazoyl]. II Farmaco, Edizione Pratica. 1966;21(4):204-23.
- 38. Ruffolo RR. Distribution and function of peripheral α-adrenoceptors in the cardiovascular system. Pharmacology Biochemistry and Behavior. 1985;22(5):827-33.10.1016/0091-3057(85)90535-0
- 39. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000;20(10):907-18.10.1046/j.1468-2982.2000.00146.x11304026
- 40. Sortino S, Giuffrida S, Scaiano JC. Photogeneration of hydrated electrons, nitrogen-centered radicals and singlet oxygen from naphazoline: a laser flash photolysis study. Photochemistry and Photobiology. 1999;70(4):590-5.10.1111/j.1751-1097.1999.tb08256.x
- 41. Takeuchi K, Akatsuka K, Kasuya Y. Pharmacological studies of imidazoline derivatives. II. Actions on cardiovascular system and acute toxicity. J. Pharmacobiodyn. 1986;9(4):385-394.10.1248/bpb1978.9.3852874206
- 42. Vitezic D, Rozmanic V, Franulovic J, Ahel V, Matesic D Naphazoline nasal drops intoxication in children. Arh Hig Rada Toksikol. 1994;45(1):25-9.
- 43. Warren MR, Werner HW. Acute toxicity of vasopressor amines II. Comparative data. J Pharmacol Exp Ther. 1946;86(3):280-3.
- 44. Watanabe Y, Hongo S, Matsumoto M. Evaluation of excised loach skin for studies on transdermal permeation of drugs in vitro. Yakugaku zasshi: Journal of the Pharmaceutical Society of Japan. 1989;109(9):656-61.10.1248/yakushi1947.109.9_6562607415
- 45. Wenzel S, Sagowski C, Laux G, Kehrl W, Metternich FU. Course and therapy of intoxication with imidazoline derivate naphazoline. Int J Pediatr Otorhinolaryngol. 2004;68(7):979-83.10.1016/j.ijporl.2004.02.01115183593
- 46. Willems EW, Valdivia LF, Villalon CM, Saxena PR. Possible role of alpha-adrenoceptor subtypes in acute migraine therapy. Chephalalgia., 2003;23 (4):245–57.
- 47. Winston C. Hainsworth. Accidental poisoning with naphazoline («PRIVINE») hydrochlorid. Am J Dis Child. 1948;75(1):76-80.
- 48. Yamadori Y, Oiso N, Hirao A, Kawara S, Kawada A. Allergic contact dermatitis from dibucaine hydrochloride, chlorpheniramine maleate, and naphazoline hydrochloride in an over-the-counter topical antiseptic. Contact Dermatitis. 2009;61(1):52-3.10.1111/j.1600-0536.2009.01556.x19659969
- 49. Yonkman FF, Rennick B, Schwerma HL. Pharmacologic studies of a new vasoconstrictor: 2-naphthyl-(1‘)-methyl-imidazoline hydrochloride (Privine or Naphazoline): III. An attempt to localize the seat of action in terms of adrenergic and cholinergic foci. J Pharmacol Exp Ther. 1944;82(3):275-87.
- 50. Zarechnova N, Tursunov R. Study the impact of decongestants (naftizine) on the morphology of the mucosa of the nasal cavity of rats. Bulletin KRSU. 2012;12(2):163-6.
- 51. Zavala J A, Pereira ER, Zetola VH, Teive HA, Novak EM, Werneck LC. Hemorrhagic stroke after naphazoline exposition: case report. Arq Neuropsiquiatr. 2004;62(3B):889-91.10.1590/S0004-282X200400050003015476091